Circulating immune checkpoints predict heart failure outcomes
Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...
Hlavní autoři: | Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Wiley
2023-08-01
|
Edice: | ESC Heart Failure |
Témata: | |
On-line přístup: | https://doi.org/10.1002/ehf2.14304 |
Podobné jednotky
-
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
Autor: Douglas B. Johnson, a další
Vydáno: (2019-05-01) -
Checkpoint Inhibition in Myeloma: Opportunities and Challenges
Autor: Federica Costa, a další
Vydáno: (2018-09-01) -
The role of immune checkpoints in cardiovascular disease
Autor: Laura I. Yousif, a další
Vydáno: (2022-10-01) -
Enhancing cancer care with improved checkpoint inhibitors
Autor: Vickram A S, a další
Vydáno: (2024-10-01) -
Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
Autor: Ruby Dhar, a další
Vydáno: (2023-04-01)